Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
NCT00289185Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2006
- Primary completion
- Feb 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of RTS,S in malaria, hepatitis B (HBV), sponsored by GSK. Started Sep 2006; status: completed.
02
Drugs
RTS,S
03
Conditions
malariahepatitis B (HBV)
Beyond the preview
Go deeper on NCT00289185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289185.